FDA to introduce new Covid-19 vaccine protocol after report claims shots killed 10 children The FDA will also review its guidance for annual flu shots, according to a memo The Independent UK · Nov 29, 2025
A small Texas think tank cultivated COVID dissidents. Now they’re running U.S. health policy. People with ties to Brownstone Institute have significant authority over access to vaccines and scientific research. The Texas Tribune · Nov 19, 2025
Turmoil and tensions at FDA after dramatic exit of top drug regulator Scramble to find replacement for George Tidmarsh shines light on dysfunction at US regulatory agency The Guardian - US · Nov 15, 2025
Chaos at the FDA leaves staffers disturbed, ready to leave Questions over reliability have risen over the underperforming and dysfunctional FDA. Axios · Nov 4, 2025
FDA Outlines Process To Speed Up Rare Disease Therapy Approvals The U.S. Food and Drug Administration on Thursday introduced the Rare Disease Evidence Principles (RDEP) to provide greater speed and predictability in the review of therapies intended to treat rare diseases with very small patient populations. Benzinga · Sep 4, 2025
FDA Official Pressures YouTube Into Removing a Channel For Posting His Own Vaccine Comments Not long ago, conservatives were rightly concerned about jawboning. Now they're apparently happy to take part in it themselves. Reason · Sep 3, 2025
Over 1,000 HHS staffers demand RFK Jr resign as civil war swirls over his remaking of the agency Employees past and present come togther to express lack of confidence in Robert F Kennedy Jr over turbulent leadership of America’s public health institutions The Independent UK · Sep 3, 2025
Top FDA official demands removal of YouTube videos in which he criticized Covid vaccines Channel was an attempt to ‘preserve’ what officials in current Trump administration said during the pandemic The Guardian - US · Aug 31, 2025
MAGA firebrand Laura Loomer breaks with Trump in rare public spat over 600k China student visas: ‘Do the math’ Loomer, who has the ear of the president, criticized him after he hailed the ‘very important relationship’ with Beijing The Independent UK · Aug 26, 2025
RFK Jr denies 2028 presidential ambitions after attacks from Trump influencer Laura Loomer HHS chief took to social media with deference to president after ‘Trump’s Rasputin’ said he was plotting move The Guardian - US · Aug 16, 2025
Laura Loomer sets her sights on her next target to get the boot from the Trump administration ‘I’m not naive enough to think that the president is going to get rid of RFK, but I will say that … there are concerns about some of the staffing decisions over at HHS,’ Laura Loomer said this week. The Independent UK · Aug 13, 2025
Ousted FDA vaccine chief Vinay Prasad is returning to the agency A Food and Drug Administration official who stepped down less than two weeks ago is getting his job back as the agency’s top vaccine regulator The Independent UK · Aug 11, 2025
Vinay Prasad's Comeback To FDA Sparks Debate Over Regulatory Direction In a stunning reversal, Dr. Vinay Prasad is returning to his role as director of the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER), just days after his resignation. Benzinga · Aug 11, 2025
Trump news at a glance: Lutnick threatens Harvard patents; former Fox commentator bound for UN Commerce secretary begins process could let the government seize Harvard patents; Tammy Bruce nominated for deputy US ambassador to UN – key US politics stories from 9 August 2025 The Guardian - AU · Aug 10, 2025
The Guardian - US · Aug 9, 2025 Vinay Prasad returns to FDA days after leaving under pressure from Laura Loomer Prasad left the agency after far-right influencer released edited audio misleadingly suggesting he was anti-Trump
The Independent UK · Aug 7, 2025 Laura Loomer names the MAGA rep she says the Trump admin ‘can’t stand’ Loomer testifies in HBO lawsuit deposition that a high-profile congresswoman is disliked, despite her outspoken loyalty to the president
The Independent UK · Aug 6, 2025 Laura Loomer says a friend calls her ‘Trump’s Rasputin’ as her surprising influence grows in White House Right-wing conspiracy theorist, 32, says she told president he has a ‘vetting crisis’ in his administration
The Independent UK · Aug 5, 2025 Laura Loomer’s MAGA critics accuse her of being funded by Big Pharma ‘I do not work for Big Pharma. I work in support of President Trump on the outside of the administration,’ Loomer tells The Independent
Benzinga · Aug 4, 2025 Why Is Replimune Stock Trading Lower On Monday? On Monday, Replimune Group Inc. (NASDAQ:REPL) is reeling after the FDA unexpectedly rejected its skin cancer treatment, triggering a stock plunge and a wave of investor outrage.
We Got This Covered · Aug 1, 2025 Laura Loomer just admitted she’s running a ‘tip line’ to get Trump officials fired and predicts ‘hundreds’ more pink slips Loomer's purge machine.
We Got This Covered · Jul 31, 2025 ‘Progressive leftist saboteur’: How Laura Loomer’s single-handely got Donald Trump’s choice fired Loomer's latest victory.
International Business Times UK · Jul 30, 2025 Vinay Prasad vs the FDA: How One Doctor's Policies Collided with Politics and Cost Him His Job Vinay Prasad resigns from the FDA after backlash over vaccine restrictions and gene therapy decisions. Political pressure cited in sudden departure.
Benzinga · Jul 30, 2025 What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday? In May, FDA Commissioner Marty Makary named Vinay Prasad the next director of the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER). Within three months, Prasad resigned.
The Guardian - US · Jul 30, 2025 FDA’s top vaccine official leaves post after less than four months Trump administration gives no details about reason for departure of Vinay Prasad, but he had critics and had taken unusual actions
The Independent UK · Jul 21, 2025 FDA names former pharmaceutical company executive to oversee US drug program The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program